-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, CRRC Group received the "Reply on Issues Related to the Non-public Issuance of A Shares by CRRC" issued by the State-owned Assets Supervision and Administration Commission of the State Council, and the State-owned Assets Supervision and Administration Commission of the State Council agreed in principle to the company's plan
for the non-public offering of A shares.
According to the fixed increase plan, CRRC intends to issue no more than 1.
386 billion shares at 8.
66 yuan per share, and the total amount of funds raised will not exceed 12 billion yuan, of which 6 billion yuan will be used to repay interest-bearing liabilities, and the remaining raised funds will be used to supplement working capital
.
Among the target of the issuance, CRRC Group, the company's controlling shareholder, intends to subscribe for about 6 billion yuan, and China Development Bank Capital, China Development Bank Investment and Development, Xinghan Asset Management and Shanghai CMB intend to subscribe for about 1.
5 billion yuan, 1.
5 billion yuan, 2 billion yuan and 1 billion yuan
respectively.
According to the announcement, CRRC's plan for the non-public offering of A-shares is subject to the approval of the company's shareholders' general meeting and the approval of the China Securities Regulatory Commission before it can be implemented
.
In the secondary market, as of the close of trading on June 13, CRRC A shares closed at 9.
04 yuan per share
.
Recently, CRRC Group received the "Reply on Issues Related to the Non-public Issuance of A Shares by CRRC" issued by the State-owned Assets Supervision and Administration Commission of the State Council, and the State-owned Assets Supervision and Administration Commission of the State Council agreed in principle to the company's plan
for the non-public offering of A shares.
According to the fixed increase plan, CRRC intends to issue no more than 1.
386 billion shares at 8.
66 yuan per share, and the total amount of funds raised will not exceed 12 billion yuan, of which 6 billion yuan will be used to repay interest-bearing liabilities, and the remaining raised funds will be used to supplement working capital
.
Among the target of the issuance, CRRC Group, the company's controlling shareholder, intends to subscribe for about 6 billion yuan, and China Development Bank Capital, China Development Bank Investment and Development, Xinghan Asset Management and Shanghai CMB intend to subscribe for about 1.
5 billion yuan, 1.
5 billion yuan, 2 billion yuan and 1 billion yuan
respectively.
According to the announcement, CRRC's plan for the non-public offering of A-shares is subject to the approval of the company's shareholders' general meeting and the approval of the China Securities Regulatory Commission before it can be implemented
.
In the secondary market, as of the close of trading on June 13, CRRC A shares closed at 9.
04 yuan per share
.
